Reimbursement Mechanisms: The Role of the EBM and GOÄ in Laboratory Financing
Financing for laboratory services in Germany follows a dual system based on the patient's insurance status. For the approximately 90% of the population covered by Statutory Health Insurance (SHI), reimbursement is governed by the Uniform Value Scale (EBM). The EBM sets fixed points and prices for every laboratory service, which are billed directly by the laboratory to the Associations of Statutory Health Insurance Physicians (Kassenärztliche Vereinigungen).
For patients with Private Health Insurance (PHI), billing follows the Official Fee Schedule for Physicians (GOÄ). The GOÄ typically allows for higher reimbursement rates than the EBM. A critical component of the German system is the "laboratory budget" for GPs; doctors are allocated a specific budget for laboratory orders, and exceeding this can lead to financial penalties (regressions). This mechanism is designed to prevent "over-testing" while ensuring that medically necessary diagnostics remain accessible to all citizens regardless of income.